All Stories

  1. Safety and Efficacy of Finerenone in Diabetic Kidney Disease: A Single-Center Retrospective Real-World Comparative Study of Dosing and Clinical Decision-Making in Taiwan
  2. Associations between phthalate exposure and kidney injury in chronic kidney disease
  3. Effectiveness of Eicosapentaenoic and Docosahexaenoic Acid Supplementation for Reducing Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
  4. Multicenter analysis of SARS-CoV-2 vaccination and infection in patients with end-stage kidney disease
  5. Elevated urinary phthalate levels in endometrial cancer patients: Evidence from a comparative study
  6. The Role of Duplex Ultrasound and Flow/Pressure Ratio in Predicting Invasive Treatment for High Venous Pressure in Patients Undergoing Hemodialysis
  7. Correction: Ng et al. Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome. Nutrients 2021, 13, 4088
  8. Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway
  9. Human Poisoning with Methomyl and Cypermethrin Pesticide Mixture
  10. Interleukin-18 and Gelsolin Are Associated with Acute Kidney Disease after Cardiac Catheterization
  11. Real-World Effectiveness of SARS-CoV-2 Vaccine Booster in Hemodialysis Patients with COVID-19 Receiving Molnupiravir
  12. Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women
  13. Updates on the Pivotal Roles of Mitochondria in Urothelial Carcinoma
  14. Exogenous BMP7 administration attenuated vascular calcification and improved bone disorders in chronic uremic rats
  15. Predictors of Acute Kidney Disease Severity in Hospitalized Patients with Acute Kidney Injury
  16. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
  17. Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis
  18. Association between Enzyme-Linked Immunosorbent Assay-Measured Kidney Injury Markers and Urinary Cadmium Levels in Chronic Kidney Disease
  19. Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway
  20. The Risk Factors of Blood Cadmium Elevation in Chronic Kidney Disease
  21. Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
  22. Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome
  23. The AST-120 Recovers Uremic Toxin-Induced Cognitive Deficit via NLRP3 Inflammasome Pathway in Astrocytes and Microglia
  24. Dapagliflozin and xanthine oxidase inhibitors improve insulin resistance and modulate renal glucose and urate transport in metabolic syndrome
  25. Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases
  26. Review of Traditional Chinese Medicines for Common Complications Related to Hemodialysis: An Evidence-Based Perspective
  27. Recent Advances in Microfluidic Devices for Contamination Detection and Quality Inspection of Milk
  28. Associations between Circulating Markers of Cholesterol Homeostasis and Macrovascular Events among Patients Undergoing Hemodialysis
  29. Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis
  30. Recent advances in lab-on-paper diagnostic devices using blood samples
  31. Effect of clinical factors on trajectory of functional performance in patients undergoing hemodialysis
  32. Mutual Interaction of Clinical Factors and Specific microRNAs to Predict Mild Cognitive Impairment in Patients Receiving Hemodialysis
  33. Importance of non-medical reasons for dropout in patients on peritoneal dialysis
  34. Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
  35. Correlation of sociodemographic profiles with psychological problems among hospitalized patients receiving unplanned hemodialysis
  36. Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism
  37. Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
  38. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice
  39. The Number of Comorbidities Predicts Renal Outcomes in Patients with Stage 3–5 Chronic Kidney Disease
  40. Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients
  41. Goal attainment and renal outcomes in patients enrolled in the chronic kidney disease care program in Taiwan: a 3-year observational study
  42. Impact of risk factors on functional status in maintenance hemodialysis patients
  43. Factors associated with magnesemia in patients with chronic kidney disease
  44. Chronic Kidney Disease-Mineral and Bone Disorder
  45. Mitochondrial Fission Increases Apoptosis and Decreases Autophagy in Renal Proximal Tubular Epithelial Cells Treated with High Glucose
  46. Mitochondrial DNA variants as genetic risk factors for Parkinson disease
  47. Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines
  48. Gelsolin and Progression of Aortic Arch Calcification in Chronic Hemodialysis Patients
  49. Serum Potassium Profile and Associated Factors in Incident Peritoneal Dialysis Patients
  50. Serum Alkaline Phosphatase Levels are Not Associated with Increased Death Risk in Prevalent Hemodialysis Patients: 5-Year Experience in a Single Hemodialysis Center
  51. FP454THE PATHOGENIC ROLES OF TOLL-LIKE RECEPTOR 4 SIGNALING IN DIABETIC TUBULOPATHY
  52. Indoxyl Sulfate-Induced Oxidative Stress, Mitochondrial Dysfunction, and Impaired Biogenesis Are Partly Protected by Vitamin C and N-Acetylcysteine
  53. Gelsolin and Adipokines Are Associated With Protein-Energy Wasting in Hemodialysis Patients
  54. Preventive SNP–SNP interactions in the mitochondrial displacement loop (D-loop) from chronic dialysis patients
  55. Genetic algorithm-generated SNP barcodes of the mitochondrial D-loop for chronic dialysis susceptibility
  56. Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
  57. Asymmetric Dimethylarginine Is Associated with Developmental Programming of Adult Kidney Disease and Hypertension in Offspring of Streptozotocin-Treated Mothers
  58. Mitochondrial DNA Coding and Control Region Variants as Genetic Risk Factors for Type 2 Diabetes
  59. Sequence-Based Polymorphisms in the Mitochondrial D-Loop and Potential SNP Predictors for Chronic Dialysis
  60. Relationship between Kt/V urea-based dialysis adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients
  61. Albuminuria, Proteinuria, and Urinary Albumin to Protein Ratio in Chronic Kidney Disease
  62. Lack of modulatory effect of simvastatin on indoxyl sulfate-induced activation of cultured endothelial cells
  63. Acute Multiple Organ Failure in Adult Mice Deleted for the Developmental Regulator Wt1
  64. Interleukin 10 and residual kidney function are associated with risk of vascular calcification in patients undergoing peritoneal dialysis
  65. Low-Molecular-Weight Heparin Successfully Used to Treat a Nephrotic Patient Complicated by Superior Mesenteric Vein Thrombosis and Portal Vein Thrombosis
  66. Mitochondrial DNA copy number correlates with oxidative stress and predicts mortality in nondiabetic hemodialysis patients
  67. Dact2 is expressed in the developing ureteric bud/collecting duct system of the kidney and controls morphogenetic behavior of collecting duct cells
  68. Proinflammatory Cytokines, Hepatocyte Growth Factor and Adipokines in Peritoneal Dialysis Patients
  69. FACTORS ASSOCIATED WITH BLOOD CONCENTRATIONS OF INDOXYL SULFATE AND p-CRESOL IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
  70. Lack of association between mutations of gene-encoding mitochondrial D310 (displacement loop) mononucleotide repeat and oxidative stress in chronic dialysis patients in Taiwan
  71. Preserved Residual Kidney Function after Twelve Years' Hemodialysis
  72. SPLENIC INFARCTION AS A CAUSE OF ACUTE ABDOMINAL PAIN IN NEPHROTIC SYNDROME
  73. Association Between C-Reactive Protein and Biomarkers of Bone and Mineral Metabolism in Chronic Hemodialysis Patients: A Cross-Sectional Study
  74. Polyphenol Extracts fromHibiscus sabdariffaLinnaeus Attenuate Nephropathy in Experimental Type 1 Diabetes
  75. Factors Determining Cardiovascular and Renal Outcomes after Adrenalectomy in Patients with Aldosterone-Producing Adrenal Adenoma
  76. Successful Treatment of Bilateral Emphysematous Pyelonephritis in a Uremic Patient without Nephrectomy
  77. Epithelial branching: The power of self-loathing
  78. Varicella-Zoster Infection with Encephalopathy, Pneumonia, and Renal Failure: A Case Report
  79. Effects of Parathyroidectomy on Iron Homeostasis and Erythropoiesis in Hemodialysis Patients with Severe Hyperparathyroidism